Latest News

02.18.19

MacuLogix Relocates to Larger Headquarters in Harrisburg, Pennsylvania to Accommodate Growth

Source: MacuLogix

02.15.19

UnitedHealthcare Vision Plans Rank Highest in Customer Satisfaction in J.D. Power Report

Source: UnitedHealthcare

02.15.19

Diabetes Eye Exam Frequency in US Is ‘Alarmingly Low’

Source: Medscape

02.15.19

VSY Biotechnology and Carl Zeiss Meditec Settle Legal Disputes

Source: VSY Biotechnology

02.14.19

Leiters and Mobius Therapeutics Enter into National Sales and Marketing Agreement for Mitosol

Source: Leiters

02.14.19

Registration Now Open for Neuro-Optometric Rehabilitation Association Meeting

Source: Neuro-Optometric Rehabilitation

02.14.19

New Medscape Report Finds More Than One in Three Doctors are Burned Out

Source: Medscape

02.14.19

Ocugen Granted FDA Orphan Drug Designation for OCU400 Gene Therapy for Retinal Degenerative Disease

Source: Ocugen

02.13.19

Eyenovia Confirms Expanded MicroProst Phase 3 Indication to Enroll Broad Patient Population for IOP Lowering

Source: Eyenovia

02.13.19

Zeiss and CBM Partner to Open New Training Center for Ophthalmologists in Pune, India

Source: Zeiss

02.13.19

Bausch + Lomb Receives 510(k) Clearance For Use Of The Tangible Hydra-PEG Custom Contact Lens Coating

Source: Bausch + Lomb

02.13.19

Melt Pharmaceuticals Improves Patent Estate for Sublingual Non-Opioid Pain and Sedation Formulations

Source: Melt Pharmaceuticals

02.12.19

Ophtec’s Precizon Presbyopic IOL with Continuous Transitional Focus (CTF) Optic Now Patented in the US

Source: Ophtec

02.12.19

Neurotech Pharmaceuticals Granted Fast Track Designation from the FDA for the Treatment of Macular Telangiectasia Type 2

Source: Neurotech Pharmaceuticals

02.12.19

Pr3vent Completes Series A Financing Led By InFocus Capital Partners

Source: Pr3vent

View more stories